65-- Radioactive Therasphere

NOTICE OF INTENT TO SOLE SOURCE THERASPHERE, Y-90 GLASS MICROSPHERE The Department of Veterans Affairs, Louis Stokes Cleveland VA Medical Center, 10701 East Boulevard, Cleveland, OH 44106, intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b)(1) soliciting from one source when CO determines that the circumstances of the contract action deem only one source reasonably available. The VA intends to solicit and negotiate with Biocompatibles, Inc., 115 Hurley Road, Building 3, Oxford, CT 06478, for Therasphere, Y-90 Glass Microsphere Therapeutic doses. Therasphere is a therapeutic agent used to treat unresectable primary Hepatocellular Carcinoma. It consists of microscopic glass spheres that are attached to a radioactive isotope (y-90) and then injected into the patient. The spheres are trapped in the liver where they can treat liver cancer. The Government believes that only one business can reasonably satisfy the agency requirements and intends to negotiate with only one source. Other Contractors may identify their interest and capability by responding to this requirement by Wednesday, June 5, 2019, by 2:00PM EST. Such capabilities information will be used solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. All information shall be furnished at no cost or obligation to the Government. A determination by the Government not to open the requirement to competition based upon responses to this notice is solely within the discretion of the Government. No solicitation is available now. All inquiries must be submitted by email to Tanesha Reese at [email protected] with the subject: RFQ 36C25019Q0780 Therasphere, Y-90 Glass Microsphere.